A Study Comparing the Differences Between Young and Non-young Breast Cancer

N/AEnrolling By InvitationNCT06793306

Cancer Institute and Hospital, Chinese Academy of Medical Sciences3,000 enrolled

Overview

To collect data on diagnosis, treatment, survival prognosis, and intrinsic molecular detection of breast cancer in China from January 2000 to December 2024.Compare the difference between young and non-young breast cancer.

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

Breast Cancer

Interventions

AgeOTHER

Breast cancer patients were divided into young breast cancer and non-young breast cancer by age 35

combination therapyOTHER

To observe and compare the difference in diagnosis, combined treatment and prognosis between young and non-young breast cancer

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * During the period from January 2000 to December 2024, the first breast cancer diagnosed and treated in several hospitals in China was in the age range of 18-75 years. Exclusion Criteria: * Breast cancer patients under 18 years of age or over 75 years of age; Combined with other malignant tumors; Patients with chronic infectious diseases or chronic infectious diseases; Patients with severe comorbidities, with serious dysfunction of vital organs (heart, liver, kidney); Known history of human immunodeficiency virus; The investigator concluded that patients should not be included in other conditions of this trial.

Locations (1)

Cancer Hospital, Chinese Academy of Medical Sciences

Beijing, China

Outcomes

Primary Outcomes

Overall survival rate

Time frame: 10-year

Secondary Outcomes

invasive disease-free survival rate

Time frame: 10-year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.